Current and new-generation transcatheter aortic valve devices: an update on emerging technologies

References

• Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363(17), 1597–1607 (2010).
   PubMed Web of Science ®Google Scholar
• Kodali SK, Williams MR, Smith CR et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 366(18), 1686–1695 (2012).
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364(23), 2187–2198 (2011).
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24), 3006–3008 (2002).
   PubMed Web of Science ®Google Scholar
• Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113(6), 842–850 (2006).
   PubMed Web of Science ®Google Scholar
• Thomas M, Schymik G, Walther T et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122(1), 62–69 (2010).
   PubMed Web of Science ®Google Scholar
• Thomas M, Schymik G, Walther T et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 124(4), 425–433 (2011).
   PubMed Web of Science ®Google Scholar
• Mussardo M, Latib A, Chieffo A et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the SAPIEN XT as compared with the Edwards SAPIEN valve. JACC Cardiovasc. Interv. 4(7), 743–750 (2011).
   PubMed Web of Science ®Google Scholar
• Bourantas CV, Farooq V, Onuma Y, Piazza N, Van Mieghem NM, Serruys PW. Transcatheter aortic valve implantation: new developments and upcoming clinical trials. EuroIntervention 8(5), 617–627 (2012).
   PubMed Web of Science ®Google Scholar
• Piazza N, Grube E, Gerckens U et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4(2), 242–249 (2008).
   PubMedGoogle Scholar
• Linke A, Gerckens U, Wenaweser P et al. Treatment of high risk aortic stenosis patients with transcatheter Medtronic CoreValve implantation: results form the international multi-center ADVANCE study. J. Am. Coll. Cardiol. (59), 8 (2012).
   Google Scholar
• Eltchaninoff H, Prat A, Gilard M et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur. Heart J. 32(2), 191–197 (2011).
   PubMed Web of Science ®Google Scholar
• Bates MG, Matthews IG, Fazal IA, Turley AJ. Postoperative permanent pacemaker implantation in patients undergoing trans-catheter aortic valve implantation: what is the incidence and are there any predicting factors? Interact. Cardiovasc. Thorac. Surg. 12(2), 243–253 (2011).
   PubMed Web of Science ®Google Scholar
• Binder RK, Rodes-Cabau J, Wood DA et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc. Interv. 6(3), 293–300 (2013).
   PubMed Web of Science ®Google Scholar
• Binder RK, Schafer U, Kuck KH et al. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system. JACC Cardiovasc. Interv. 6(3), 301–307 (2013).
   PubMed Web of Science ®Google Scholar
• Sinning JM, Werner N, Nickenig G, Grube E. The CoreValve Evolut 23 mm: the first member of a new family. Eurointervention 8, Q94–96 (2012).
   Google Scholar
• Sinning JM, Werner N, Vasa-Nicotera M et al. Innovations and novel technologies in TAVI. Second generation transcatheter heart valves. Minerva. Cardioangiol. 61(2), 155–163 (2013).
   PubMed Web of Science ®Google Scholar
• Schofer J, Schluter M, Treede H et al. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study. Circ. Cardiovasc. Interv. 1(2), 126–133 (2008).
   PubMed Web of Science ®Google Scholar
• Bijuklic K, Tuebler T, Reichenspurner H et al. Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis. Up to 2-year follow-up of the direct-flow medical valve: a pilot study. Circ. Cardiovasc. Interv. 4(6), 595–601 (2011).
   PubMed Web of Science ®Google Scholar
• Latib A. Evaluation of the direct flowmedical percutaneous aortic valve 18F system for the treatment of patients with severe aortic stenosis. Six-months results from the discover trial. Presented at: 62nd Annual Meeting of the American College of Cardiology. San Francisco, California, USA, 9–11 March 2013.
   Google Scholar
• Willson AB, Rodes-Cabau J, Wood DA et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J. Am. Coll. Cardiol. 60(7), 581–586 (2012).
   PubMed Web of Science ®Google Scholar
• Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter. Cardiovasc. Interv. 71(5), 579–584 (2008).
   PubMed Web of Science ®Google Scholar
• Meredith IT, Hood K, Haratani N, Allocco D, Dawkins K. Boston scientific lotus valve. Eurointervention 8, Q70–Q74 (2012).
   PubMed Web of Science ®Google Scholar
• Kempfert J, Rastan AJ, Beyersdorf F et al. Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes. Eur. J. Cardiothorac. Surg. 40(5), 1114–1119 (2011).
   PubMed Web of Science ®Google Scholar
• Moellmann H. Symetis accurate™ trans-femoral first-in-man results. Presented at: PCR London Valves. London, UK, 11–12 October 2012.
   Google Scholar
• Kempfert J, Rastan AJ, Mohr FW, Walther T. A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve. Eur. J. Cardiothorac. Surg. 40(3), 761–763 (2011).
   PubMed Web of Science ®Google Scholar
• Treede H, Mohr FW, Baldus S et al. Transapical transcatheter aortic valve implantation using the JenaValve system: acute and 30-day results of the multicentre CE-mark study. Eur. J. Cardiothorac. Surg. 41(6), e131–138 (2012).
   Web of Science ®Google Scholar
• Falk V, Walther T, Schwammenthal E et al. Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur. Heart J. 32(7), 878–887 (2011).
   PubMed Web of Science ®Google Scholar
• Piazza N. Colibri heart valve: glimpse to the future. Presented at: EuroPCR Congress. Paris, France. 15–18 May 2012.
   Google Scholar
• Thubrikar M. The optimum TAV. Presented at: PCR London Valves. London, UK, 11–12 October 2012.
   Google Scholar
• Feldman T, Leon MB. Prospects for percutaneous valve therapies. Circulation 116(24), 2866–2877 (2007).
   PubMed Web of Science ®Google Scholar
• Latib A, Messika-Zeitoun D, Maisano F et al. Reversible Edwards SAPIEN XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J. Am. Coll. Cardiol. 61(7), 787–789 (2013).
   PubMed Web of Science ®Google Scholar
• Rodes-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat. Rev. Cardiol. 9(1), 15–29 (2011).
   PubMed Web of Science ®Google Scholar
• Meredith IT. Repositionable percutaneous replacement of a stenotic aortic valve through implantation of the lotus valve system. Presented at: EuroPCR Congress 2012. Paris, France, 15–18 May 2012.
   Google Scholar
• Cai J, Sheng Y, Zhang S et al. Preliminary feasibility and hemodynamic performance of a newly-developed self-expanding bioprosthesis and 16-F delivery system in transcatheter aortic valve implantation in sheep. J. Biomed. Res. 26(3), 211–218 (2012).
   PubMedGoogle Scholar